For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
3.6 - 3.6 mg
From 3.6 To 3.6 mg once every 28 day(s)
One 3.6 mg depot of goserelin injected subcutaneously into the anterior abdominal wall, every 28 days.